Brind.
  1. Citigroup raised its rating on Innate Pharma stock, which trades on the Nasdaq exchange. Leerink Partners also upgraded the rating. MarketBeat aggregates the rating data.

Leerink Partners assumed coverage on Equillium shares, with data reported by MarketBeat from Nasdaq listed stocks.

1 report, 1 independent Updated Oct 14
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.

What happened

Some supportReported by 1 outlet

Leerink Partners assumed coverage on Equillium shares, with data reported by MarketBeat from Nasdaq listed stocks.

Who's involved

What this event is mainly about
MarketBeatLeerink partnersNasdaq

Keep exploring

Part of

Citigroup raised its rating on Innate Pharma stock, which trades on the Nasdaq exchange. Leerink Partners also upgraded the rating. MarketBeat aggregates the rating data. All 1 developments

The entities involved

Related events

Coverage

Newest first; wire copies grouped